EUCTR2018-003869-33-NL进行中（未招募）1 期
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients. - OPTI-CLOT: TARGET
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Hemophilia A and B patients of all ages on prophylaxis;
- •-Prophylaxis with SHL factor concentrate or EHL factor concentrate;
- •-Written (parental) informed consent, according to local law and regulations
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 25
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •-Patients with other congenital or acquired hemostatic abnormalities;
- •-General medical conditions which may interfere with participation in the study;
- •-Inability to adhere to prophylaxis and/ or inability to keep detailed logs of infusions and bleeding episodes;
- •-Withdrawal of (parental) informed consent.
研究者
相似试验
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patientsNL-OMON27791Erasmus Medical Center, Sophia Children's Hospital50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.hemophiliaNL-OMON55874Erasmus MC, Universitair Medisch Centrum Rotterdam50
招募中
不适用
Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand diseaseNL-OMON54546Erasmus MC, Universitair Medisch Centrum Rotterdam160
进行中（未招募）
1 期
Effects of pharmacokinetic models in dosing of DDAVP and/or von Willebrand factor-containing concentrates in patients with von Willebrand diseaseVon Willebrand diseaseMedDRA version: 20.0Level: LLTClassification code 10055168Term: Von Willebrand's factor deficiencySystem Organ Class: 100000004850EUCTR2018-001631-46-NLErasmus University Medical Center120
已完成
不适用
Development of a method for better estimation of warfarin dose in patients requiring warfarin therapyCTRI/2018/06/014614Dr Nusrat Shafiq82